Abstract:BACKGROUND:With the development of industry and agriculture, organotin compounds have been widely used in China. Organotin compounds cause a common occupational poisoning. The toxicity of organotin was reported in animal studies; however the reports about human organotin intoxication are very rare. In this study we retrospectively analyzed the clinical manifestations of 15 organotin-poisoned patients who had been treated at our hospital from 2002 through 2007.METHODS:Fifteen patients with organotin poisoning were admitted to Sir Run Run Shaw Hospital Affiliated to Zhejiang University School of Medicine from 2002 to 2007. They were 9 males and 6 females, aged from 25 to 52 years. Clinical manifestations and Glasgow Coma Scales showed that the poisoning was mild in 4 patients, moderate in 6 and severe in 5. The severe patients were given glucocorticoid after hospitalization by intravenous guttae of 500 mg methylprednisolone for the first day, followed by 160 mg methylprednisolone per day for three days, and then 80 mg methylprednisolone per day for another three days. Potassium glutamate and sodium glutamate were intravenously dripped to reduce blood ammonia; intravenous guttae plus oral administration of potassium 9 g/day was used to correct intractable hypokalemia; sodium bicarbonate was used to correct metabolic acidosis, and sedatives were used to control spasm and twitch; mechanical ventilators were used in 4 patients with dyspnea.RESULTS:Most of the patients showed elevated level of blood ammonia, decreased level of blood potassium and metabolic acidosis, but some had demyelination changes shown by CT and MRI. Treatments included correction of metabolic acids, blood potassium and ammonia, and mechanical ventilation when necessary. For patients with injuries of the nervous system, glucocorticoids were given immediately after hospitalization. These patients showed intractable hypokalemia and metabolic acidosis during the treatment. Forteen patients recovered completely without long-term side-effect. One patient in the aphasiac stage restored the linguistic capacity during a 6-month follow-up.CONCLUSIONS:Elevated level of blood ammonia, decresed level of blood potassium, and metabolic acidosis are common in patients with organotin poisoning. Demyelination can be observed in patients with severe poisoning. The abnormalities of the patients are reversible after suitable treatments.

POTASSIUM IODATE TOXIC RETINOPATHY: A Report of Five Cases

Iodate induced toxic retinopathy: a case report

Iodine-Induced Retinopathy: A Case Report

Diagnosis and Treatment of Organotin Poisoned Patients.

Iopromide-induced acute renal failure

Acute hemolysis following iodine tincture ingestion

Retinal neurodegeneration induced by sodium iodate administration and visual cortex activity

Effects of 3,5-Diiodotyrosine and Potassium Iodide on Thyroid Function and Oxidative Stress in Iodine-Excess Wistar Rats

CHEMICAL OCULAR INJURY BY POTASSIUM PERMANGANATE

The dangers of iodine-based contrasts in an elderly patient with thyroid disease

Case Report: A case of Kounis syndrome induced by iodine contrast agent during coronary angiography

Effect of iodinated contrast media on peripheral blood mononuclear cells in terms of cell viability, cell cycle and oxidative stress in an in vitro system

Potassium Iodide Use and Patient Outcomes for Thyroid Storm: An Observational Study

Early effects of sodium iodate injection on pattern VEP of rabbits

Aseptic encephalitis and blindness complicating OKT3 therapy

Acute iodine toxicity from a suspected oral methamphetamine ingestion

Thyroid Dysfunction Risk After Iodinated Contrast Media Administration: A Prospective Longitudinal Cohort Analysis

Inhibitory effect of low-dose inorganic iodine on thyroidal radioactive iodine uptake in healthy Japanese adults

Protection and safety of a repeated dosage of KI for iodine thyroid blocking during pregnancy

In vitro investigation the effects of iodinated contrast media on endothelial cell viability, cell cycle, and apoptosis

[Iodine excess induced thyroid dysfunction]